Revenue expected to grow 1,529.20% this year.

Aimmune Therapeutics, Inc. has had a beautiful uptrend since it spiked in Sept, pulled back in a falling wedge, popped out of the wedge and ran up to the resistance level, formed another falling wedge, and then ran five waves up.